73 related articles for article (PubMed ID: 8882461)
1. Inhibition mechanisms of staurosporine and H7 to cAMP-dependent protein kinase through docking study.
Takagi A; Yamada Mizutani M; Tomioka N; Itai A
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):618-20. PubMed ID: 8882461
[TBL] [Abstract][Full Text] [Related]
2. Parthenogenetic activation of pig eggs by exposure to protein kinase inhibitors.
Prather RS; Mayes MA; Murphy CN
Reprod Fertil Dev; 1997; 9(5):539-44. PubMed ID: 9418984
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of spontaneous acetylcholine secretion by 2-chloroadenosine as revealed by a protein kinase inhibitor at the mouse neuromuscular junction.
Hirsh JK; Silinsky EM
Br J Pharmacol; 2002 Apr; 135(8):1897-902. PubMed ID: 11959792
[TBL] [Abstract][Full Text] [Related]
4. Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential.
Prade L; Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
Structure; 1997 Dec; 5(12):1627-37. PubMed ID: 9438863
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity.
Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
J Biol Chem; 1996 Oct; 271(42):26157-64. PubMed ID: 8824261
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of docking strategies for virtual screening of compound databases: cAMP-dependent serine/threonine kinase as an example.
Godden JW; Stahura F; Bajorath J
J Mol Graph Model; 1998 Jun; 16(3):139-43, 165. PubMed ID: 10434253
[TBL] [Abstract][Full Text] [Related]
7. Staurosporine and H7 attenuate ethanol-induced elevation in [Ca2+]i in cultured canine cerebral vascular smooth muscle cells.
Zheng T; Li W; Zhang A; Altura BT; Altura BM
Neurosci Lett; 1998 Jan; 241(2-3):139-42. PubMed ID: 9507940
[TBL] [Abstract][Full Text] [Related]
8. Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411.
Furet P; Caravatti G; Lydon N; Priestle JP; Sowadski JM; Trinks U; Traxler P
J Comput Aided Mol Des; 1995 Dec; 9(6):465-72. PubMed ID: 8789188
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
Jarvis WD; Turner AJ; Povirk LF; Traylor RS; Grant S
Cancer Res; 1994 Apr; 54(7):1707-14. PubMed ID: 7511048
[TBL] [Abstract][Full Text] [Related]
10. Effect of protein kinase modulators on the regulation of cathepsin B activity in THP-1 human monocytic leukemia cells.
Li Q; Bever CT
Oncol Rep; 1998; 5(1):227-33. PubMed ID: 9458327
[TBL] [Abstract][Full Text] [Related]
11. Ca2+-dependent and Ca2+-independent regulation of the thyroid epithelial junction complex by protein kinases.
Nilsson M; Fagman H; Ericson LE
Exp Cell Res; 1996 May; 225(1):1-11. PubMed ID: 8635501
[TBL] [Abstract][Full Text] [Related]
12. Effect of myosin light chain kinase, protein kinase A, and protein kinase C inhibition on porcine oocyte activation.
Green KM; Kim JH; Wang WH; Day BN; Prather RS
Biol Reprod; 1999 Jul; 61(1):111-9. PubMed ID: 10377038
[TBL] [Abstract][Full Text] [Related]
13. The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity.
Fournès B; Sadekova S; Turbide C; Létourneau S; Beauchemin N
Oncogene; 2001 Jan; 20(2):219-30. PubMed ID: 11313949
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of G-protein coupled receptor kinase 2: docking and biochemical evaluation of inhibitors.
Kassack MU; Högger P; Gschwend DA; Kameyama K; Haga T; Graul RC; Sadée W
AAPS PharmSci; 2000; 2(1):E2. PubMed ID: 11741218
[TBL] [Abstract][Full Text] [Related]
15. Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways.
Milkiewicz P; Roma MG; Elias E; Coleman R
Gut; 2002 Jul; 51(1):113-9. PubMed ID: 12077103
[TBL] [Abstract][Full Text] [Related]
16. Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol?
Frazier EP; Mathy MJ; Peters SL; Michel MC
J Pharmacol Exp Ther; 2005 Apr; 313(1):260-7. PubMed ID: 15576470
[TBL] [Abstract][Full Text] [Related]
17. Insulin inhibits secretin-induced ductal secretion by activation of PKC alpha and inhibition of PKA activity.
Lesage GD; Marucci L; Alvaro D; Glaser SS; Benedetti A; Marzioni M; Patel T; Francis H; Phinizy JL; Alpini G
Hepatology; 2002 Sep; 36(3):641-51. PubMed ID: 12198656
[TBL] [Abstract][Full Text] [Related]
18. Radiation augments a sequential program of differentiation in PKC inhibitor- pretreated mouse epidermal cells.
Yi MJ; Kim TH; Lee SJ; Cho CK; Bae IH; Lee YS
J Radiat Res; 1999 Sep; 40(3):273-84. PubMed ID: 10641489
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of kinase A and C blockers on lordosis facilitation by progesterone and its metabolites in ovariectomized estrogen-primed rats.
González-Flores O; Ramírez-Orduña JM; Lima-Hernández FJ; García-Juárez M; Beyer C
Horm Behav; 2006 Mar; 49(3):398-404. PubMed ID: 16256992
[TBL] [Abstract][Full Text] [Related]
20. (RP)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition.
Dostmann WR
FEBS Lett; 1995 Nov; 375(3):231-4. PubMed ID: 7498506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
